Overview
VNRX market data
Price History
VNRX price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$4.37 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.19 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.73 – $15.10 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $8.8 · P/B 9.37 · P/S 3.57.
Company News
8-K filing — VOLITIONRX LTD (VNRX)SEC EDGAR · Jul 21, 2026, 8:15 PM
VolitionRX Files Prospectus Related To Offer And Resale Of Up To 3.31M Shares By Selling StockholderBenzinga · Jul 10, 2026, 9:35 PM
VolitionRx Publishes Paper On The Prognostic Value Of Its Nu.Q Cancer Assay In Newly Diagnosed Lung Cancer PatientsBenzinga · Jul 7, 2026, 12:30 PM
VolitionRx Partners With Sysmex To Streamline Volition's Nu.Q NETs H3.1 AssayBenzinga · Jun 17, 2026, 12:20 PM
U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Response EffortsBenzinga · Jun 5, 2026, 6:30 PM
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable MarketsBenzinga · May 27, 2026, 1:15 PM
Full Transcript: VolitionRX Q1 2026 Earnings CallBenzinga · May 15, 2026, 1:50 PM
VolitionRX Q1 EPS $(0.97) Misses $(0.75) Estimate, Sales $985.076K Beat $426.600K EstimateBenzinga · May 14, 2026, 8:26 PM
Earnings Scheduled For May 14, 2026Benzinga · May 14, 2026, 11:11 AM